Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab-Reference-Cited by-同舟云学术

Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab

Published:2015-10 Issue:9 Volume:46 Page:950-954
ISSN:2325-8160
Container-title:Ophthalmic Surgery, Lasers and Imaging Retina
language:en
Short-container-title:Ophthalmic Surg Lasers Imaging Retina

Author:

Wood Edward H.,Karth Peter A.,Moshfeghi Darius M.,Leng Theodore

Publisher

SLACK, Inc.

Subject

Ophthalmology,Surgery

Reference20 articles.

1. One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

2. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

3. Evolving strategies in the management of diabetic macular edema: clinical trials and current management

4. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group;Ophthalmology,1991

5. Photocoagulation for Diabetic Macular Edema

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema;International Ophthalmology;2024-06-25

2. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods;Survey of Ophthalmology;2023-03

3. Effect of age on response to anti-VEGF agents in patients with center involving diabetic macular edema in a tertiary hospital;International Journal of Retina and Vitreous;2022-12-13

4. Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review;Survey of Ophthalmology;2022-09

5. Functional and structural characteristics in patients with diabetic macular oedema after switching from ranibizumab to aflibercept treatment. Three year results in real world settings;International Journal of Retina and Vitreous;2022-04-01